Aligos Therapeutics Inc (NQ: ALGS )
1.183 +0.003 (+0.24%) Streaming Delayed Price Updated: 11:54 AM EDT, Jun 7, 2023 Add to My Watchlist
Headline News about Aligos Therapeutics Inc
LaNova Medicines has sold global rights for a pre-clinical antibody drug conjugate candidate to AstraZeneca for $600 million, including $55 million upfront plus royalties on sales. Meanwhile, Amoytop...
Via Talk Markets
Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
May 15, 2023
Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.
Recap: Aligos Therapeutics Q1 Earnings
May 04, 2023
Aligos Therapeutics Earnings Preview
May 03, 2023
A Preview Of Aligos Therapeutics's Earnings
March 08, 2023
Aligos Co-Founders File Complaint Against Johnson & Johnson Alleging Fraud
September 29, 2022
Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 17, 2023
Gainers Celyad Oncology SA (NASDAQ: CYAD) jumped 187% to $2.30 after gaining 21% on Friday. Celyad Oncology, last month, decided to discontinue the development of its remaining clinical program...
12 Health Care Stocks Moving In Monday's After-Market Session
January 16, 2023
12 Health Care Stocks Moving In Friday's Intraday Session
January 06, 2023
SVB Leerink Maintains Market Perform Rating for Aligos Therapeutics: Here's What You Need To Know
November 03, 2022
SVB Leerink has decided to maintain its Market Perform rating of Aligos Therapeutics (NASDAQ:ALGS) and lower its price target from $3.00 to $2.00. Shares of Aligos Therapeutics are trading up 0.0% over...
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023
January 06, 2023
Aligos Therapeutics, Inc. (NASDAQ: ALGS) has initiated enrollment in a 12-week dosing cohort of HBeAg-positive chronic hepatitis B (CHB) subjects in the ongoing Phase 1b study ALG-000184-201.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following